CannLabs, Inc.
CANL · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $6,505 | $8,221 | $11,547 | $23,338 |
| - Cash | $651 | $405 | $327 | $265 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,854 | $7,816 | $11,219 | $23,073 |
| Revenue | $1,233 | $1,100 | $1,053 | $1,006 |
| % Growth | 12.1% | 4.4% | 4.7% | – |
| Gross Profit | $643 | $402 | $457 | $561 |
| % Margin | 52.1% | 36.5% | 43.4% | 55.8% |
| EBITDA | $367 | $105 | $114 | $294 |
| % Margin | 29.8% | 9.6% | 10.9% | 29.2% |
| Net Income | $364 | $103 | $111 | $291 |
| % Margin | 29.5% | 9.3% | 10.6% | 28.9% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | 300% | 0% | -75% | – |
| Operating Cash Flow | $338 | $306 | $62 | $67 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $338 | $306 | $62 | $67 |